Google plans to release new ‘open’ AI models for drug discovery
SMRTR summary
Google's TxGemma AI models, designed for drug discovery, interpret text and molecular structures to predict therapeutic properties, aiming to streamline the drug development process through the Health AI Developer Foundations program, despite mixed results in AI's impact on pharmaceutical research.
SMRTR provides this summary for quick context. The original article belongs to Daily.dev.
Read the original article